Back to Search Start Over

Patterns of chromosomal imbalances in invasive breast cancer

Authors :
Karsten Schlüns
Iver Petersen
Klaus Jürgen Winzer
Anke Schwendel
Manuela Pacyna-Gengelbach
Manfred Dietel
Janusz Szymas
Barbara Fleige
Frank Richard
Source :
International journal of cancer. 89(3)
Publication Year :
2000

Abstract

Invasive breast carcinomas are characterized by a complex pattern of chromosomal alterations. We applied comparative genomic hybridization (CGH) to analyze 105 primary breast carcinomas using histograms to indicate the incidence of DNA imbalances of tumor subgroups and difference histograms to compare invasive ductal carcinomas (IDC) with lobular carcinomas (ILC), well and poorly differentiated carcinomas (G1/G3) and estrogen receptor-positive and -negative tumors (ER+/ER−). Only single imbalances showed a higher incidence in ILC compared with IDC, i.e., gains on chromosomes 4 and 5q13–q23 as well as deletions on chromosomes 6q, 11q14-qter, 12p12-pter, 16q, 17p, 18q, 19, and 22q. Of these, particularly gains of 4 and losses at 16q21–q23, and 18q12–q21 were statistically significant. For most loci, IDC showed more alterations providing a genetic correlate to the fact that ductal carcinoma overall is associated with a worse prognosis than ILC. Of these, many imbalances showing statistical significance were also observed in G3 and ER− tumors, i.e., deletions at 2q35–q37, 3p12—p14, 4p15–p16, 5q, 7p15, 8p22–p23, 10q, 11p, 14q21–q31, 15q, and gains at 2p, 3q21–qter, 6p, 8q21-qter, 10p, 18p11–q11, and 20q, suggesting that they contribute to a more aggressive tumor phenotype. By contrast, gains on chromosome 5q13–q23 as well as deletions at 6q, 16q and 22q were more prevalent in G1 and ER+ tumors. The ratio profiles of all cases as well as histograms are accessible at our CGH online tumor database at http://amba.charite.de/cgh. Our results highlight distinct chromosomal subregions for cancer-associated genes. In addition, these imbalances may serve as markers for a genetic classification of invasive breast cancer. Int. J. Cancer 89:305–310, 2000. © 2000 Wiley-Liss, Inc.

Details

ISSN :
00207136
Volume :
89
Issue :
3
Database :
OpenAIRE
Journal :
International journal of cancer
Accession number :
edsair.doi.dedup.....e2f09bf6cd1aef3ad12f27f095c4f981